GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
10d
News Medical on MSNNew study confirms GLP-1 medications are safe for mental health in diabetesResearchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...
Ozempic and its ilk may do a lot of things, but raising the risk of suicide doesn’t appear to be one of them. Research out ...
8d
Medpage Today on MSNUse of GLP-1 Drugs for Obesity Linked to Lower Risk of GlaucomaUse of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...
A study presented at the 2025 Annual Meeting of the American Academy of Orthopaedic Surgeons examined the relationship between the patient's last dose of Ozempic, a common GLP-1, and ...
Doctors also might consider starting with lower doses of GLP-1 drugs and slowly increasing them for people with severe diabetes or a history of eye problems, he added. More research is needed to ...
8d
News Medical on MSNStudy shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
“GLP-1 receptor agonist use was not associated with an increased risk of suicidal ideation, self-harm, or suicide” compared ...
Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.
People taking the drugs had a lower risk of organ failure and death However, the drugs were associated with an increased risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results